Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.75M.
ENTERPRISE VALUE (EV)
$2.75M
Jupiter Neurosciences, Inc.
Market Cap
$1.24M
Enterprise Value (EV)
$2.75M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.24M | $2.75M |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | $862091.00 |
| NewcelX Ltd. (NCEL)vs › | $1.33M | $1.01M |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | $9.68M |
| Genprex, Inc. (GNPX)vs › | $1.36M | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | $2.14M |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.40M | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.41M | $8.38M |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | N/A |
Market Cap
$1.24M
Total Debt
$5.30M
Cash
$3.79M
Enterprise Value
$2.75M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
